相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
Yaqiong Zhan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial-Mesenchymal Transition
Yongmei Zhao et al.
FRONTIERS IN CHEMISTRY (2021)
Metastasis-on-a-chip reveals adipocyte-derived lipids trigger cancer cell migration via HIF-1α activation in cancer cells
Jieun Seo et al.
BIOMATERIALS (2021)
Synergistic ferroptosis and macrophage re-polarization using engineering exosome-mimic M1 nanovesicles for cancer metastasis suppression
Ping Li et al.
CHEMICAL ENGINEERING JOURNAL (2021)
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Investigation of the Therapeutic Potential of a Synergistic Delivery System through Dual Controlled Release of Camptothecin-Doxorubicin
Yongmei Zhao et al.
ADVANCED THERAPEUTICS (2020)
Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy
Jingchao Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy
Wen Liao et al.
ACTA BIOMATERIALIA (2019)
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Akram Pourshams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation
Piaopiao Wang et al.
THERANOSTICS (2019)
An update on treatment options for pancreatic adenocarcinoma
Aurelien Lambert et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
Shuhei Shinoda et al.
Oncotarget (2018)
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Sophia G. Antimisiaris et al.
PHARMACEUTICS (2018)
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
Lifang Cheng et al.
MOLECULAR THERAPY (2017)
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer et al.
PANCREATOLOGY (2017)
Imidazole-modified deferasirox encapsulated polymeric micelles as pH-responsive iron-chelating nanocarrier for cancer chemotherapy
Man Theerasilp et al.
RSC ADVANCES (2017)
Promising molecular mechanisms responsible for gemcitabine resistance in cancer
Yanfei Jia et al.
GENES & DISEASES (2015)
A comprehensive overview of exosomes as drug delivery vehicles - Endogenous nanocarriers for targeted cancer therapy
Kasper Bendix Johnsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells
Hong-juan Yao et al.
BIOMATERIALS (2014)
Quasi-spherical microwells on superhydrophobic substrates for long term culture of multicellular spheroids and high throughput assays
Tianqing Liu et al.
BIOMATERIALS (2014)
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
Yanhua Tian et al.
BIOMATERIALS (2014)
Quantitative synchrotron X-ray fluorescence study of the penetration of transferrin-conjugated gold nanoparticles inside model tumour tissues
Tianqing Liu et al.
NANOSCALE (2014)
ABC transporters in CSCs membranes as a novel target for treating tumor relapse
Laura Zinzi et al.
FRONTIERS IN PHARMACOLOGY (2014)
An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
Sarah B. Fisher et al.
CANCER (2013)
Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition
Karl Quint et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
Minyong Chen et al.
ONCOLOGY REPORTS (2012)
Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
Jie-Er Ying et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
Hayato Fujita et al.
NEOPLASIA (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Effect of food, type of food, and time of food intake on deferasirox bioavailability:: Recommendations for an optimal deferasirox administration regimen
Renzo Galanello et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
Takao Itoi et al.
JOURNAL OF GASTROENTEROLOGY (2007)
分享论文
